MS PHARMA

mspharma.com

MS Pharma is a leading pharmaceutical, healthcare solutions provider and partner of choice company that is manufacturing and marketing generic medicines through its leading affiliates in several strategic markets across the MENA region. The company is headquartered in Jordan, It unifies EL KENDI in Algeria, UPM in Jordan, MS Pharma Injectables and MS Pharma Turkey. MS Pharma is committed to offer high quality generic medicines with added value by basing its production on new technologies and state-of-the-art facilities implemented all around the MENA region.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

NPPA SLAMS PHARMA GIANTS FOR OVERCHARGING

IIFL (India Infoline Group) | March 07, 2017

news image

The price regulator in the pharmaceutical industry, National Pharmaceutical Price Authority (NPPA) has discovered that the leading Pharma companies are overcharging customers for abundantly prevalent drugs in the market....

Read More

CPD and Learning

APPLIED BIOMATH, LLC ANNOUNCES PARTNERSHIP WITH ANTENGENE FOR SYSTEMS PHARMACOLOGY MODELING IN ONCOLOGY

Applied BioMath | December 09, 2020

news image

Applied BioMath, the business chief in applying frameworks pharmacology and unthinking demonstrating, reproduction, and examination to de-hazard drug innovative work, today reported a joint effort with Antengene Corporation for the advancement of a frameworks pharmacology displaying in immuno-oncology. Applied BioMath will build up a frameworks pharmacology model for a PDL1/41BB bispecific immunizer, ATG-101, in immuno-oncology signs. The model will be utilized to anticipate clinical beginning a...

Read More

Business Insights

APPLIED BIOMATH, LLC ANNOUNCES COLLABORATION WITH BYOMASS™ FOR SYSTEMS PHARMACOLOGY MODELING IN ONCOLOGY

Applied BioMath | October 18, 2021

news image

Applied BioMath, the industry-leader in applying systems pharmacology and mechanistic modeling, simulation, and analysis to de-risk drug research and development, today announced a collaboration with BYOMass, Inc. for systems pharmacology modeling in chronic diseases. BYOMass is a preclinical stage pharmaceutical company focused on the TGF-ß superfamily. "We chose Applied BioMath given their proven track record of helping companies identify ideal therapeut...

Read More

GROUND-BREAKING COLLABORATION TO OFFER NEW HEART DISEASE DRUG TO NHS PATIENTS

Pharmacy Business | January 14, 2020

news image

The government on Monday announced a collaboration with Novartis to launch a clinical trial for ‘yet to be approved’ drug inclisiran. The drug could benefit thousands of patients at risk of heart disease in coming years. The ground-breaking collaboration includes Novartis, NHS England and the National Institute for Health Research (NIHR) and Oxford University. The Department of Health and Social Care (DHSC) expects this to position the UK as a world-leading destination to develop cut...

Read More
news image

NPPA SLAMS PHARMA GIANTS FOR OVERCHARGING

IIFL (India Infoline Group) | March 07, 2017

The price regulator in the pharmaceutical industry, National Pharmaceutical Price Authority (NPPA) has discovered that the leading Pharma companies are overcharging customers for abundantly prevalent drugs in the market....

Read More
news image

CPD and Learning

APPLIED BIOMATH, LLC ANNOUNCES PARTNERSHIP WITH ANTENGENE FOR SYSTEMS PHARMACOLOGY MODELING IN ONCOLOGY

Applied BioMath | December 09, 2020

Applied BioMath, the business chief in applying frameworks pharmacology and unthinking demonstrating, reproduction, and examination to de-hazard drug innovative work, today reported a joint effort with Antengene Corporation for the advancement of a frameworks pharmacology displaying in immuno-oncology. Applied BioMath will build up a frameworks pharmacology model for a PDL1/41BB bispecific immunizer, ATG-101, in immuno-oncology signs. The model will be utilized to anticipate clinical beginning a...

Read More
news image

Business Insights

APPLIED BIOMATH, LLC ANNOUNCES COLLABORATION WITH BYOMASS™ FOR SYSTEMS PHARMACOLOGY MODELING IN ONCOLOGY

Applied BioMath | October 18, 2021

Applied BioMath, the industry-leader in applying systems pharmacology and mechanistic modeling, simulation, and analysis to de-risk drug research and development, today announced a collaboration with BYOMass, Inc. for systems pharmacology modeling in chronic diseases. BYOMass is a preclinical stage pharmaceutical company focused on the TGF-ß superfamily. "We chose Applied BioMath given their proven track record of helping companies identify ideal therapeut...

Read More
news image

GROUND-BREAKING COLLABORATION TO OFFER NEW HEART DISEASE DRUG TO NHS PATIENTS

Pharmacy Business | January 14, 2020

The government on Monday announced a collaboration with Novartis to launch a clinical trial for ‘yet to be approved’ drug inclisiran. The drug could benefit thousands of patients at risk of heart disease in coming years. The ground-breaking collaboration includes Novartis, NHS England and the National Institute for Health Research (NIHR) and Oxford University. The Department of Health and Social Care (DHSC) expects this to position the UK as a world-leading destination to develop cut...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us